(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
最近の投稿
- 1
UK to hold fresh pork, other affected Spanish products at border amid African swine fever outbreak - 2A Past filled with Old Civilizations: The World's Most established Societies
- 3Bird flu poses risk of pandemic worse than COVID, France's Institut Pasteur says
- 4Report in relation to renaming Herzog Park set to be withdrawn
- 5The Manual for Electric Vehicles that will be hot merchants in 2023
- The most effective method to Go Down Abundance through Ages with Disc Rates
- Vote in favor of your favored spot to peruse
- Manual for Tracking down the Immaculate Magnificence of Focal Asia
- The most effective method to Shake Hands Expertly: A Bit by bit Guide
- Well known Worldwide Caf\u00e9s to Experience
- Flat Earth, spirits and conspiracy theories – experience can shape even extraordinary beliefs
- Find the Excellence of Old style Expressive dance: Encountering the Effortlessness and Polish of Dance
- A Couple of Modest Guitars for 2024
- Japan deploys the military to counter a surge in bear attacks
